Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc. (APLS) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Apellis Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1492422.
Total stock buying since 2017: $72,055,913.
Total stock sales since 2017: $125,480,225.
Total stock option exercises since 2017: $17,781,278.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 498,012 | $12,822,188 | 87,780 | $371,300 |
| 2024 | 0 | $0 | 440,133 | $23,511,567 | 261,584 | $1,202,259 |
| 2023 | 0 | $0 | 757,461 | $46,600,892 | 1,306,608 | $7,793,855 |
| 2022 | 0 | $0 | 270,047 | $14,741,673 | 328,866 | $3,017,705 |
| 2021 | 250,000 | $10,000,000 | 95,771 | $4,885,298 | 354,966 | $2,429,947 |
| 2020 | 545,540 | $20,159,015 | 399,824 | $16,235,156 | 579,554 | $1,976,550 |
| 2019 | 452,875 | $7,847,627 | 230,001 | $6,387,115 | 327,505 | $723,388 |
| 2018 | 224,258 | $4,214,067 | 15,776 | $296,336 | 98,302 | $266,274 |
| 2017 | 2,131,086 | $29,835,204 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-15 | Machiels Alec (Director) | Option Ex | 1,250 | 2.67 | 3,337 |
| 2022-03-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 43.53 | 16,323 |
| 2022-02-23 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 4,100 | 4.31 | 17,671 |
| 2022-02-15 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 45.43 | 17,036 |
| 2022-02-15 | Machiels Alec (Director) | Sale | 1,250 | 45.43 | 56,787 |
| 2022-02-15 | Machiels Alec (Director) | Option Ex | 1,250 | 2.67 | 3,337 |
| 2022-02-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 3,600 | 4.31 | 15,515 |
| 2022-02-14 | Scheibler Lukas (CHIEF INNOVATION OFFICER) | Option Ex | 720 | 26.73 | 19,245 |
| 2022-02-11 | Scheibler Lukas (CHIEF INNOVATION OFFICER) | Sale | 1,666 | 46.80 | 77,968 |
| 2022-02-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 40.58 | 15,217 |
| 2022-01-31 | Scheibler Lukas (CHIEF INNOVATION OFFICER) | Sale | 1,233 | 38.47 | 47,433 |
| 2022-01-21 | Scheibler Lukas (CHIEF INNOVATION OFFICER) | Option Ex | 3,021 | 26.73 | 80,751 |
| 2022-01-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 40.56 | 15,210 |
| 2022-01-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 3,400 | 4.31 | 14,653 |
| 2022-01-14 | Machiels Alec (Director) | Sale | 1,250 | 40.56 | 50,700 |
| 2022-01-14 | Machiels Alec (Director) | Option Ex | 1,250 | 2.67 | 3,337 |
| 2022-01-12 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 5,161 | 4.04 | 20,824 |
| 2022-01-03 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 47.31 | 17,741 |
| 2021-12-27 | Watson David O. (General Counsel) | Sale | 1,200 | 48.50 | 58,200 |
| 2021-12-22 | Watson David O. (General Counsel) | Sale | 10,571 | 48.05 | 507,925 |
| 2021-12-22 | Watson David O. (General Counsel) | Option Ex | 20,112 | 14.40 | 289,612 |
| 2021-12-15 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 42.88 | 16,080 |
| 2021-12-15 | Machiels Alec (Director) | Sale | 3,000 | 42.88 | 128,640 |
| 2021-12-15 | Machiels Alec (Director) | Option Ex | 3,000 | 2.67 | 8,010 |
| 2021-12-08 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 7,000 | 3.76 | 26,320 |
| 2021-12-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 375 | 42.40 | 15,900 |
| 2021-11-18 | Morningside Venture Investments Ltd (10% Owner) | Buy | 250,000 | 40.00 | 10,000,000 |
| 2021-11-15 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 625 | 43.50 | 27,187 |
| 2021-11-15 | Machiels Alec (Director) | Sale | 3,000 | 43.50 | 130,500 |
| 2021-11-15 | Machiels Alec (Director) | Option Ex | 3,000 | 2.67 | 8,010 |
| 2021-11-04 | Machiels Alec (Director) | Sale | 3,000 | 35.00 | 105,000 |
| 2021-11-04 | Machiels Alec (Director) | Option Ex | 3,000 | 2.67 | 8,010 |
| 2021-11-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 625 | 30.70 | 19,187 |
| 2021-10-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 750 | 34.57 | 25,927 |
| 2021-10-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 750 | 33.26 | 24,945 |
| 2021-09-28 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 4,000 | 3.76 | 15,040 |
| 2021-09-10 | Dunlop A. Sinclair (Director) | Option Ex | 6,894 | 14.00 | 96,516 |
| 2021-09-10 | Watson David O. (General Counsel) | Option Ex | 954 | 4.31 | 4,111 |
| 2021-08-16 | Machiels Alec (Director) | Sale | 2,500 | 56.95 | 142,375 |
| 2021-08-16 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-08-02 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 250 | 63.99 | 15,997 |
| 2021-08-02 | Perry Nicole D (Vice President - Accounting) | Sale | 1,000 | 63.99 | 63,990 |
| 2021-08-02 | Perry Nicole D (Vice President - Accounting) | Option Ex | 1,000 | 3.76 | 3,760 |
| 2021-07-21 | Delong Mark Jeffrey (Senior Vice President) | Sale | 1,000 | 65.00 | 65,000 |
| 2021-07-21 | Delong Mark Jeffrey (Senior Vice President) | Option Ex | 1,000 | 15.52 | 15,520 |
| 2021-07-21 | Francois Cedric (Chief Executive Officer) | Option Ex | 14,410 | 4.31 | 62,107 |
| 2021-07-15 | Delong Mark Jeffrey (Senior Vice President) | Sale | 1,000 | 62.30 | 62,300 |
| 2021-07-15 | Delong Mark Jeffrey (Senior Vice President) | Option Ex | 1,000 | 15.52 | 15,520 |
| 2021-07-15 | Machiels Alec (Director) | Sale | 2,500 | 62.30 | 155,750 |
| 2021-07-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-07-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 500 | 64.68 | 32,340 |
| 2021-07-08 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 250 | 65.68 | 16,420 |
| 2021-06-28 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 9,000 | 3.76 | 33,840 |
| 2021-06-24 | Deschatelets Pascal (Chief Scientific Officer) | Sale | 6,250 | 65.61 | 410,062 |
| 2021-06-24 | Deschatelets Pascal (Chief Scientific Officer) | Option Ex | 6,250 | 2.67 | 16,687 |
| 2021-06-21 | Watson David O. (General Counsel) | Option Ex | 489 | 4.31 | 2,107 |
| 2021-06-15 | Delong Mark Jeffrey (Senior Vice President) | Sale | 4,000 | 64.96 | 259,832 |
| 2021-06-15 | Delong Mark Jeffrey (Senior Vice President) | Option Ex | 4,000 | 15.52 | 62,080 |
| 2021-06-15 | Machiels Alec (Director) | Sale | 2,500 | 64.83 | 162,075 |
| 2021-06-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-06-08 | Sullivan Timothy Eugene (Chief Financial Officer) | Option Ex | 39,880 | 10.03 | 399,996 |
| 2021-06-01 | Perry Nicole D (Vice President - Accounting) | Sale | 1,000 | 56.40 | 56,400 |
| 2021-06-01 | Perry Nicole D (Vice President - Accounting) | Option Ex | 1,000 | 3.76 | 3,760 |
| 2021-05-28 | Watson David O. (General Counsel) | Option Ex | 489 | 4.31 | 2,107 |
| 2021-05-24 | Deschatelets Pascal (Chief Scientific Officer) | Sale | 6,250 | 47.40 | 296,250 |
| 2021-05-24 | Deschatelets Pascal (Chief Scientific Officer) | Option Ex | 6,250 | 2.67 | 16,687 |
| 2021-05-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 500 | 45.39 | 22,695 |
| 2021-05-03 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 600 | 50.73 | 30,437 |
| 2021-04-23 | Deschatelets Pascal (Chief Scientific Officer) | Sale | 6,250 | 46.13 | 288,312 |
| 2021-04-23 | Deschatelets Pascal (Chief Scientific Officer) | Option Ex | 6,250 | 2.67 | 16,687 |
| 2021-04-21 | Machiels Alec (Director) | Sale | 2,500 | 45.76 | 114,400 |
| 2021-04-21 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-04-16 | Dunlop A. Sinclair (Director) | Option Ex | 50,000 | 14.00 | 700,000 |
| 2021-04-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 500 | 42.82 | 21,410 |
| 2021-04-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 600 | 43.41 | 26,045 |
| 2021-03-22 | Watson David O. (General Counsel) | Option Ex | 978 | 4.31 | 4,215 |
| 2021-03-15 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 500 | 46.77 | 23,385 |
| 2021-03-15 | Machiels Alec (Director) | Sale | 2,500 | 46.77 | 116,925 |
| 2021-03-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-03-10 | Deschatelets Pascal (Chief Scientific Officer) | Sale | 6,250 | 50.74 | 317,125 |
| 2021-03-10 | Deschatelets Pascal (Chief Scientific Officer) | Option Ex | 6,250 | 2.67 | 16,687 |
| 2021-03-05 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 5,000 | 48.62 | 243,075 |
| 2021-03-05 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 5,000 | 3.20 | 16,000 |
| 2021-03-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 600 | 48.58 | 29,148 |
| 2021-03-01 | Perry Nicole D (Vice President - Accounting) | Sale | 2,000 | 50.00 | 100,000 |
| 2021-03-01 | Perry Nicole D (Vice President - Accounting) | Option Ex | 2,000 | 3.76 | 7,520 |
| 2021-02-16 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 500 | 46.00 | 23,000 |
| 2021-02-16 | Machiels Alec (Director) | Sale | 2,500 | 46.00 | 115,000 |
| 2021-02-16 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-02-09 | Perry Nicole D (Vice President - Accounting) | Sale | 2,000 | 50.00 | 100,000 |
| 2021-02-09 | Perry Nicole D (Vice President - Accounting) | Option Ex | 2,000 | 3.76 | 7,520 |
| 2021-02-01 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 600 | 44.00 | 26,400 |
| 2021-01-27 | Francois Cedric (Chief Executive Officer) | Option Ex | 71,777 | 4.04 | 289,620 |
| 2021-01-27 | Watson David O. (General Counsel) | Option Ex | 43,483 | 4.04 | 175,453 |
| 2021-01-25 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 15,000 | 3.48 | 52,200 |
| 2021-01-15 | Machiels Alec (Director) | Sale | 2,500 | 53.15 | 132,875 |
| 2021-01-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2021-01-14 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 4,000 | 51.99 | 207,960 |
| 2021-01-04 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 600 | 57.24 | 34,344 |
| 2021-01-04 | Perry Nicole D (Vice President - Accounting) | Sale | 2,000 | 57.24 | 114,480 |
| 2021-01-04 | Perry Nicole D (Vice President - Accounting) | Option Ex | 2,000 | 3.76 | 7,520 |
| 2020-12-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 52.16 | 260,799 |
| 2020-12-15 | Machiels Alec (Director) | Sale | 2,500 | 52.16 | 130,399 |
| 2020-12-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-12-14 | Dunlop A. Sinclair (Director) | Sale | 25,000 | 55.04 | 1,376,000 |
| 2020-12-14 | Watson David O. (General Counsel) | Sale | 8,398 | 53.24 | 447,084 |
| 2020-12-14 | Watson David O. (General Counsel) | Option Ex | 8,398 | 13.85 | 116,312 |
| 2020-12-11 | Watson David O. (General Counsel) | Sale | 9,935 | 50.00 | 496,750 |
| 2020-12-11 | Watson David O. (General Counsel) | Option Ex | 9,935 | 13.85 | 137,599 |
| 2020-12-08 | Scheibler Lukas (CHIEF INNOVATION OFFICER) | Option Ex | 7,482 | 26.73 | 199,993 |
| 2020-12-07 | Dunlop A. Sinclair (Director) | Sale | 18,564 | 50.70 | 941,287 |
| 2020-12-04 | Dunlop A. Sinclair (Director) | Sale | 6,436 | 50.55 | 325,307 |
| 2020-12-04 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 7,250 | 3.20 | 23,200 |
| 2020-12-04 | Perry Nicole D (Vice President - Accounting) | Sale | 18,000 | 50.00 | 900,000 |
| 2020-12-04 | Perry Nicole D (Vice President - Accounting) | Option Ex | 18,000 | 3.76 | 67,680 |
| 2020-12-01 | Francois Cedric (Chief Executive Officer) | Option Ex | 40,000 | 3.76 | 150,400 |
| 2020-11-16 | Grossi Federico (CHIEF MEDICAL OFFICER) | Option Ex | 5,750 | 3.20 | 18,400 |
| 2020-11-16 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 39.38 | 196,900 |
| 2020-11-16 | Machiels Alec (Director) | Sale | 2,500 | 39.38 | 98,450 |
| 2020-11-16 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-11-02 | Grossi Federico (CHIEF MEDICAL OFFICER) | Sale | 600 | 31.09 | 18,654 |
| 2020-10-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 34.46 | 172,300 |
| 2020-10-15 | Machiels Alec (Director) | Sale | 2,500 | 35.00 | 87,500 |
| 2020-10-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-10-07 | Brown Victoria L. (Program Team Lead) | Sale | 12,000 | 35.00 | 420,000 |
| 2020-10-07 | Brown Victoria L. (Program Team Lead) | Option Ex | 12,000 | 18.98 | 227,760 |
| 2020-10-07 | Machiels Alec (Director) | Sale | 7,500 | 35.00 | 262,500 |
| 2020-10-07 | Machiels Alec (Director) | Option Ex | 7,500 | 2.67 | 20,025 |
| 2020-10-01 | Grossi Federico (See Remarks) | Sale | 600 | 30.22 | 18,132 |
| 2020-09-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 30.96 | 154,800 |
| 2020-09-01 | Grossi Federico (See Remarks) | Sale | 600 | 31.58 | 18,948 |
| 2020-08-20 | Francois Cedric (Chief Executive Officer) | Sale | 3,457 | 30.00 | 103,710 |
| 2020-08-18 | Francois Cedric (Chief Executive Officer) | Sale | 1,543 | 30.00 | 46,290 |
| 2020-08-03 | Grossi Federico (See Remarks) | Sale | 600 | 26.28 | 15,768 |
| 2020-07-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 32.12 | 160,600 |
| 2020-07-01 | Grossi Federico (See Remarks) | Sale | 850 | 32.43 | 27,565 |
| 2020-06-15 | Grossi Federico (See Remarks) | Sale | 856 | 30.21 | 25,859 |
| 2020-06-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 30.21 | 151,050 |
| 2020-06-15 | Machiels Alec (Director) | Sale | 2,500 | 30.21 | 75,525 |
| 2020-06-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-05-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 29.92 | 149,600 |
| 2020-05-15 | Machiels Alec (Director) | Sale | 2,500 | 30.00 | 75,000 |
| 2020-05-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-05-08 | Fonteyne Paul R. (Director) | Buy | 5,000 | 31.81 | 159,035 |
| 2020-04-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 29.77 | 148,850 |
| 2020-04-15 | Machiels Alec (Director) | Sale | 2,500 | 30.00 | 75,000 |
| 2020-04-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-03-25 | Machiels Alec (Director) | Sale | 2,500 | 30.00 | 75,000 |
| 2020-03-25 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-03-17 | Francois Cedric (Chief Executive Officer) | Option Ex | 30,637 | 2.14 | 65,563 |
| 2020-03-16 | Francois Cedric (Chief Executive Officer) | Sale | 35,637 | 21.86 | 778,882 |
| 2020-03-16 | Francois Cedric (Chief Executive Officer) | Option Ex | 30,637 | 2.14 | 65,563 |
| 2020-02-19 | Francois Cedric (Chief Executive Officer) | Option Ex | 30,637 | 2.14 | 65,563 |
| 2020-02-18 | Francois Cedric (Chief Executive Officer) | Sale | 35,637 | 40.66 | 1,449,178 |
| 2020-02-18 | Francois Cedric (Chief Executive Officer) | Option Ex | 30,637 | 2.14 | 65,563 |
| 2020-02-14 | Machiels Alec (Director) | Sale | 2,500 | 42.35 | 105,875 |
| 2020-02-14 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-02-13 | Deschatelets Pascal (Chief Operating Officer) | Sale | 55,398 | 40.98 | 2,270,154 |
| 2020-02-13 | Deschatelets Pascal (Chief Operating Officer) | Option Ex | 117,205 | 2.14 | 250,818 |
| 2020-02-12 | Deschatelets Pascal (Chief Operating Officer) | Sale | 52,075 | 42.80 | 2,228,966 |
| 2020-02-12 | Deschatelets Pascal (Chief Operating Officer) | Option Ex | 117,206 | 2.14 | 250,820 |
| 2020-02-10 | Watson David O. (General Counsel) | Sale | 5,000 | 44.50 | 222,500 |
| 2020-02-10 | Watson David O. (General Counsel) | Option Ex | 7,505 | 2.67 | 20,038 |
| 2020-01-27 | Watson David O. (General Counsel) | Sale | 3,000 | 40.47 | 121,401 |
| 2020-01-27 | Watson David O. (General Counsel) | Option Ex | 15,000 | 2.67 | 40,050 |
| 2020-01-16 | Francois Cedric (Chief Executive Officer) | Option Ex | 30,637 | 2.14 | 65,563 |
| 2020-01-15 | Francois Cedric (Chief Executive Officer) | Sale | 35,638 | 42.06 | 1,498,898 |
| 2020-01-15 | Francois Cedric (Chief Executive Officer) | Option Ex | 30,638 | 2.14 | 65,565 |
| 2020-01-15 | Machiels Alec (Director) | Sale | 2,500 | 41.47 | 103,675 |
| 2020-01-15 | Machiels Alec (Director) | Option Ex | 2,500 | 2.67 | 6,675 |
| 2020-01-13 | Morningside Venture Investments Ltd (10% Owner) | Buy | 540,540 | 37.00 | 19,999,980 |
| 2019-12-20 | Dunlop A. Sinclair (Director) | Sale | 25,000 | 29.53 | 738,250 |
| 2019-12-19 | Dunlop A. Sinclair (Director) | Sale | 85,110 | 29.25 | 2,489,467 |
| 2019-12-18 | Dunlop A. Sinclair (Director) | Sale | 25,890 | 28.55 | 739,159 |
| 2019-12-16 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 27.95 | 139,750 |
| 2019-11-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 27.28 | 136,405 |
| 2019-10-15 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 26.10 | 130,500 |
| 2019-09-25 | Deschatelets Pascal (Chief Operating Officer) | Sale | 21,541 | 25.44 | 548,003 |
| 2019-09-24 | Deschatelets Pascal (Chief Operating Officer) | Sale | 21,602 | 24.76 | 534,865 |
| 2019-09-23 | Deschatelets Pascal (Chief Operating Officer) | Sale | 20,858 | 25.30 | 527,686 |
| 2019-09-16 | Francois Cedric (Chief Executive Officer) | Sale | 5,000 | 26.86 | 134,320 |
| 2019-08-29 | Sullivan Timothy Eugene (Chief Financial Officer) | Buy | 11,699 | 29.71 | 347,635 |
| 2019-08-23 | Francois Cedric (Chief Executive Officer) | Option Ex | 37,505 | 2.67 | 100,138 |
| 2019-08-15 | Francois Cedric (Chief Executive Officer) | Sale | 10,000 | 26.87 | 268,710 |
| 2019-08-15 | Francois Cedric (Chief Executive Officer) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2019-08-07 | Watson David O. (General Counsel) | Option Ex | 5,000 | 2.67 | 13,350 |
| 2019-06-27 | Francois Cedric (Chief Executive Officer) | Option Ex | 275,000 | 2.14 | 588,500 |
| 2019-03-11 | Morningside Venture Investments Ltd (10% Owner) | Buy | 441,176 | 17.00 | 7,499,992 |
| 2018-11-14 | Grossi Federico (See Remarks) | Option Ex | 6,250 | 3.20 | 20,000 |
| 2018-11-14 | Axon Steven (Chief Business Officer) | Option Ex | 11,500 | 2.59 | 29,785 |
| 2018-09-21 | Morningside Venture Investments Ltd (10% Owner) | Buy | 40,000 | 19.84 | 793,600 |
| 2018-09-20 | Morningside Venture Investments Ltd (10% Owner) | Buy | 41,323 | 19.11 | 789,682 |
| 2018-09-19 | Morningside Venture Investments Ltd (10% Owner) | Buy | 60,000 | 18.09 | 1,085,400 |
| 2018-09-18 | Morningside Venture Investments Ltd (10% Owner) | Buy | 40,000 | 18.47 | 738,800 |
| 2018-09-17 | Morningside Venture Investments Ltd (10% Owner) | Buy | 40,000 | 18.67 | 746,800 |
| 2018-09-14 | Watson David O. (General Counsel) | Sale | 15,776 | 18.78 | 296,336 |
| 2018-09-14 | Watson David O. (General Counsel) | Option Ex | 32,818 | 2.67 | 87,624 |
| 2018-05-29 | Watson David O. (General Counsel) | Option Ex | 624 | 2.67 | 1,666 |
| 2018-05-24 | Scheibler Lukas (See Remarks) | Buy | 2,935 | 20.37 | 59,785 |
| 2018-04-11 | Grossi Federico (See Remarks) | Option Ex | 8,500 | 3.20 | 27,200 |
| 2018-02-20 | Axon Steven (Chief Business Officer) | Option Ex | 38,610 | 2.59 | 99,999 |
| 2017-11-13 | Venbio Global Strategic Fund Ii L.p. (10% Owner) | Buy | 127,515 | 14.00 | 1,785,210 |
| 2017-11-13 | Morningside Venture Investments Ltd (10% Owner) | Buy | 575,000 | 14.00 | 8,050,000 |
| 2017-11-13 | Hillhouse Capital Management, Ltd. | Buy | 1,428,571 | 14.00 | 19,999,994 |
Insider trading activities including stock purchases, stock sales, and option exercises of APLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Apellis Pharmaceuticals, Inc. (symbol APLS, CIK number 1492422) see the Securities and Exchange Commission (SEC) website.